Abstract

In the present work, we tested in SCID and Balb/c mice the activity of T cell hybridoma transfected with T cell receptor (TCR) α β chain genes. A T cell hybridoma denoted D011107 was used as recipient for transfection of cytotoxic KB5C20 TCR α β heterodimer genes by protoplast fusion or electroporation. After transfection, the parental D011107 T cell line reexpressed CD5 and CD4 surface molecules. In vitro, we noted strong proliferation and unusual cytotoxic reactivities against H-2 k target cells although the transfected cell line does not express the CD8 molecule. The fate of parental and transfected cells was examined in severe combined immunodeficient (SCID) and Balb/c mice at Day 16 after intravenous injection. Cells from bone marrow, thymus, and spleen tissues were analyzed by immunofluorescence. The transfected T cell hybridoma was CD3 + Desire 1 + CD4 + Thy 1.2 +. The SCID mice grafted with the transfected T cell hybridoma presented a high percentage of CD3 + (15%), CD4 + (27%), Thy1.2 + (27.52%), and Desire 1 + (8.74%) cells in the spleen. The percentages of CD3 + (6.2%) and Thy1.2 + (5.06%) cells in the spleen from SCID mice grafted with parental T cell D011107 and from untreated SCID were similar and lower (CD3 +, 3.52%; Thy1.2 +, 4.34%). It seems that transfected T cells hybridoma grafted in the SCID mice induce significant expression of CD4 + Thy1.2 + Desire 1 − cells (17%) in the spleen. These results indicate that transfected T cells graft may allow T cell differentiation. In Balb/c mice, the percentage of different T cell subsets in bone marrow, thymus, or spleen cells in mice injected with transfected T cells was similar to that in untreated mice. We did not observe any cytotoxic or significant allogeneic proliferation in vitro.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call